Veterans Affairs Medical Center Fresno, Calif
To the Editor:
The article by Eagle et al1 provides interesting
data that may have important implications in the management of patients
with coronary artery disease (CAD) who are scheduled for
noncardiac surgery. This is an extremely interesting and complex
subject, in part because of the difficulty in assessing cardiac risk in
CAD patients and because of the paucity of data to guide management
strategies aimed at reducing the risk of perioperative
cardiac complications.
Indeed, there is an urgent need for management tactics in CAD patients
to reduce or suppress perioperative coronary
events (myocardial infarction [MI] or cardiac death). In this regard,
the authors accomplished a superb task in summarizing data from the
CASS trial.1,2
There are, however, some issues of concern in this report. The data
presented in this study1 appear to be
derived from retrospective observations in patients from the CASS
registry and randomized groups3 who underwent
noncardiac surgeries. In the design of CASS, a portion of patients from
the registry were randomized to treatment according to specific
clinical and angiographic criteria.3 Because
treatment of CAD was dictated by physician and patient
preference,1 it is likely that significant bias
was introduced into the various analyses of treatment outcomes.
It appears unlikely that use of various statistical tools while these
data are evaluated will compensate for the observational nature of the
analyses.
It is interesting to note that in the high-risk noncardiac surgery
groups (vascular, thoracic, and head and neck), patients without
evidence of CAD had higher rates of
University of Michigan Heart Care Program,
Ann Arbor, Michigan
© 1998 American Heart Association, Inc.
Correspondence
Noncardiac Surgery in CAD Patients
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1998 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |